Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Meet the CVB 40 Under 40 | Another win for Wegovy | Key benefits of cardiovascular IT systems | New tirzepatide data | AI & IVUS

News You Need to Know Today
Meet the CVB 40 Under 40 | Another win for Wegovy | Key benefits of cardiovascular IT systems | New tirzepatide data | AI & IVUS
Monday, March 23, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiovascular Business announces its Forty Under 40 Class of 2026

The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 

READ MORE >
cvb forty under 40 teaser
Share on Twitter Share on Facebook Share on Linkedin

Cardiovascular Business announces its Forty Under 40 Class of 2026

Share on Twitter Share on Facebook Share on Linkedin
cvb forty under 40 teaser
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 
READ MORE >

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 

READ MORE >
overweight patient seeking health advice
Share on Twitter Share on Facebook Share on Linkedin

Another win for Wegovy: FDA approves higher semaglutide dose as part of new pilot program

Share on Twitter Share on Facebook Share on Linkedin
overweight patient seeking health advice
Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 
READ MORE >

9 ways cardiovascular IT systems can improve your day-to-day workflow

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

READ MORE >
Workflow efficiencies and automation enhance newer cardiovascular IT systems
Share on Twitter Share on Facebook Share on Linkedin

9 ways cardiovascular IT systems can improve your day-to-day workflow

Share on Twitter Share on Facebook Share on Linkedin
Workflow efficiencies and automation enhance newer cardiovascular IT systems
Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.
READ MORE >

Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial. 

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Early use of tirzepatide after heart attack or stroke linked to key cardiovascular benefits

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial. 
READ MORE >

AI-powered CCTA assessments show ‘close agreement’ with IVUS

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

READ MORE >
Example of an automated artificial intelligence (AI) assessment of soft coronary plaque from a CT scan from the vendor Cleerly. This image shows the AI's reconstruction of a patient's coronary tree and color codes the vessel segments by the amount of overall plaque burden. The AI gives a very detailed report of all the plaque in all the coronary vessels. Some cardiology experts believe this may be the way of the future in screening patients for early coronary disease and monitoring the impact of prevention
Share on Twitter Share on Facebook Share on Linkedin

AI-powered CCTA assessments show ‘close agreement’ with IVUS

Share on Twitter Share on Facebook Share on Linkedin
Example of an automated artificial intelligence (AI) assessment of soft coronary plaque from a CT scan from the vendor Cleerly. This image shows the AI's reconstruction of a patient's coronary tree and color codes the vessel segments by the amount of overall plaque burden. The AI gives a very detailed report of all the plaque in all the coronary vessels. Some cardiology experts believe this may be the way of the future in screening patients for early coronary disease and monitoring the impact of prevention
Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 
READ MORE >

Featured Articles

FDA-approved surgical aortic valve implanted for first time in US

The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.

READ MORE >
corcym Perceval Plus LANCELOT
Share on Twitter Share on Facebook Share on Linkedin

FDA-approved surgical aortic valve implanted for first time in US

Share on Twitter Share on Facebook Share on Linkedin
corcym Perceval Plus LANCELOT
The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.
READ MORE >

EP advocacy group details 6 key policy issues

The Heart Rhythm Society's advocacy arm is monitoring such issues as prior authorization, outpatient payment policies and cancelled research funding. 

READ MORE >
Congress Senate Washington D.C. DC
Share on Twitter Share on Facebook Share on Linkedin

EP advocacy group details 6 key policy issues

Share on Twitter Share on Facebook Share on Linkedin
Congress Senate Washington D.C. DC
The Heart Rhythm Society's advocacy arm is monitoring such issues as prior authorization, outpatient payment policies and cancelled research funding. 
READ MORE >

FDA clears MiniMed’s screenless, smartphone-controlled insulin pump

Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology. 

READ MORE >
MiniMed Flex Medtronic
Share on Twitter Share on Facebook Share on Linkedin

FDA clears MiniMed’s screenless, smartphone-controlled insulin pump

Share on Twitter Share on Facebook Share on Linkedin
MiniMed Flex Medtronic
Just weeks after separating from Medtronic and going public, MiniMed secured FDA clearance for its next-generation insulin pump technology. 
READ MORE >

Morning exercise may have added benefits for the heart

With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.

READ MORE >
heart patient stretching at home
Share on Twitter Share on Facebook Share on Linkedin

Morning exercise may have added benefits for the heart

Share on Twitter Share on Facebook Share on Linkedin
heart patient stretching at home
With exercise, does timing really matter? According to one new study, working out early in the day was linked to a lower risk of heart disease and healthier blood pressure levels than working out at any other point in the day.
READ MORE >

In Case You Missed It

FDA clears AI-powered platform that personalizes care during TAVR, cardiac pacing procedures

The newly cleared CARA System from Cara Medical was designed to help clinicians before and during a variety of cardiac procedures. It provides a personalized 3D map of the patient's cardiac conduction system and then overlays that map onto live fluoroscopic images.

READ MORE >
simulation of the conduction pathway relative to various cardiac structures.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears AI-powered platform that personalizes care during TAVR, cardiac pacing procedures

Share on Twitter Share on Facebook Share on Linkedin
simulation of the conduction pathway relative to various cardiac structures.
The newly cleared CARA System from Cara Medical was designed to help clinicians before and during a variety of cardiac procedures. It provides a personalized 3D map of the patient's cardiac conduction system and then overlays that map onto live fluoroscopic images.
READ MORE >

Excessive alcohol use increases risk of amputation in CLTI patients

Identifying patients with alcohol use disorder prior to treatment may help care teams plan ahead and anticipate potential complications.

READ MORE >
smoking and drinking
Share on Twitter Share on Facebook Share on Linkedin

Excessive alcohol use increases risk of amputation in CLTI patients

Share on Twitter Share on Facebook Share on Linkedin
smoking and drinking
Identifying patients with alcohol use disorder prior to treatment may help care teams plan ahead and anticipate potential complications.
READ MORE >

PFO closure after thromboembolism linked to strong 20-year outcomes

Recurrent strokes and TIAs were rare, though bleeding events among women did stand out as a trend to watch going forward.

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

PFO closure after thromboembolism linked to strong 20-year outcomes

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Recurrent strokes and TIAs were rare, though bleeding events among women did stand out as a trend to watch going forward.
READ MORE >

In Other News

New York man pleads guilty to cyberstalking family of murdered UnitedHealthcare CEO

Authorities said Shane Daley, 40, began making threatening calls mere hours after Brian Thompson was shot and killed outside a hotel in Manhattan. Daley awaits sentencing and faces up to five years in prison.

READ MORE >
UnitedHealthcare CEO Brian Thompson
Share on Twitter Share on Facebook Share on Linkedin

New York man pleads guilty to cyberstalking family of murdered UnitedHealthcare CEO

Share on Twitter Share on Facebook Share on Linkedin
UnitedHealthcare CEO Brian Thompson
Authorities said Shane Daley, 40, began making threatening calls mere hours after Brian Thompson was shot and killed outside a hotel in Manhattan. Daley awaits sentencing and faces up to five years in prison.
READ MORE >

Former ACA Marketplace enrollee: ‘This is ridiculous—$1,200 and an $8,000 deductible for a healthy person. Really?’

A new KFF survey shows almost 10% of people who had an Obamacare Marketplace plan in 2025 decided to head into 2026 with no coverage at all. Another 28% re-enrolled but with a different—presumably lesser—plan. 

READ MORE >
angry executive businessman
Share on Twitter Share on Facebook Share on Linkedin

Former ACA Marketplace enrollee: ‘This is ridiculous—$1,200 and an $8,000 deductible for a healthy person. Really?’

Share on Twitter Share on Facebook Share on Linkedin
angry executive businessman
A new KFF survey shows almost 10% of people who had an Obamacare Marketplace plan in 2025 decided to head into 2026 with no coverage at all. Another 28% re-enrolled but with a different—presumably lesser—plan. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Optimism about cardiology’s future | HRS leader looks ahead | Women live longer after TAVR | J&J announces acquisition
Preventing the most common complication after heart surgery | When bioprosthetic valves fail | Good news for Medtronic
PFA's dominance & other key EP trends | FDA approves next-gen mitral valve | Virtual nursing helps practices combat burnout
FDA's new device warning | How to implement AI-powered coronary plaque software | Key approvals for Abbott | IV fluids recalled
New SCAI president outlines focus into 2027 | DCBs have similar outcomes to DES | GLP-1s lower AFib
‘Father of modern cardiology’ dies at 96 | High-risk women missing out on care | Tirzepatide beneficial for TAVR & PCI patients
Week in Review: Cardiologist pay climbs 10% | Energy drinks & heart disease | CMS, FDA propose major change | Treating HFmrEF

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup